What are the indications and dosing guidelines for Duloxetine (Cymbalta)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Duloxetine (Cymbalta): Indications and Dosing Guidelines

Duloxetine is FDA-approved for the treatment of major depressive disorder, generalized anxiety disorder, diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain in adults. 1

FDA-Approved Indications

  • Major depressive disorder in adults 1
  • Generalized anxiety disorder in adults and pediatric patients 7 years of age and older 1
  • Diabetic peripheral neuropathic pain in adults 1
  • Fibromyalgia in adults 1
  • Chronic musculoskeletal pain in adults, including chronic low back pain and osteoarthritis pain 1, 2

Dosing Guidelines by Indication

Major Depressive Disorder

  • Starting dose: 40 mg/day (given as 20 mg twice daily) to 60 mg/day (given either once daily or as 30 mg twice daily) 1
  • For some patients, starting at 30 mg once daily for 1 week may help with adjustment 1
  • Maximum effective dose: 60 mg/day (doses up to 120 mg/day have been studied but show no additional benefit) 1

Generalized Anxiety Disorder

  • Adults <65 years: 60 mg once daily 1
  • Consider starting at 30 mg once daily for 1 week before increasing to 60 mg 1
  • Geriatric patients: Start at 30 mg once daily for 2 weeks before considering increase to 60 mg/day 1
  • Pediatric patients (7-17 years): Start at 30 mg once daily for 2 weeks before considering increase to 60 mg once daily 1
  • Recommended range for pediatric patients: 30-60 mg once daily 1

Diabetic Peripheral Neuropathic Pain

  • Standard dose: 60 mg once daily 1
  • No evidence that doses higher than 60 mg provide additional benefit 1, 3
  • Lower starting dose may be considered for patients with tolerability concerns 1
  • For patients with renal impairment, consider lower starting dose with gradual increase 1

Fibromyalgia

  • Recommended dose: 60 mg once daily 1
  • Start at 30 mg once daily for 1 week before increasing to 60 mg once daily 1
  • No evidence that doses greater than 60 mg/day provide additional benefit 1, 3

Chronic Musculoskeletal Pain

  • For chronic low back pain and osteoarthritis pain: 60 mg once daily 2, 4
  • Start at 30 mg once daily for 1 week before increasing to 60 mg once daily 4

Administration Guidelines

  • Administer orally with or without meals 1
  • Swallow capsules whole; do not chew, crush, open, or sprinkle contents 1
  • If a dose is missed, take it as soon as remembered; if close to next dose, skip missed dose 1
  • Do not take two doses at the same time 1

Special Populations and Considerations

Renal Impairment

  • Consider lower starting dose and gradual increase, especially in diabetic patients who often have concurrent renal disease 1

Hepatic Impairment

  • Use with caution in patients with hepatic impairment 5

Elderly Patients

  • For GAD: Start at 30 mg once daily for 2 weeks before considering increase 1
  • Use caution when increasing doses in elderly patients 2

Common Adverse Effects

  • Most common: nausea, dry mouth, headache, constipation, dizziness, and fatigue 2, 6
  • Nausea is most common but occurs less frequently if treatment is initiated at 30 mg daily and titrated after one week to 60 mg daily 6
  • Approximately 16% of patients discontinue due to adverse effects 3, 7

Drug Interactions

  • Avoid use with CYP1A2 inhibitors (e.g., fluvoxamine) which can increase duloxetine exposure by 460% 5
  • Avoid use with nonselective, irreversible monoamine oxidase inhibitors 6
  • Duloxetine may increase exposure of drugs metabolized by CYP2D6 5
  • Smoking may decrease duloxetine concentration by approximately 30% 5

Clinical Pearls

  • Pain relief in diabetic neuropathy may begin within one week at the 60 mg/day dose 6
  • For most pain conditions, the number needed to treat (NNT) for 50% pain reduction ranges from 5-8 3, 7
  • When discontinuing duloxetine, taper gradually to prevent withdrawal symptoms, especially after treatment longer than 3 weeks 2
  • Duloxetine offers the advantage of treating both pain and comorbid depression/anxiety when present 4

References

Guideline

Duloxetine Scheduling and Clinical Applications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia.

The Cochrane database of systematic reviews, 2014

Research

[Duloxetine for chronic pain management: pharmacology and clinical use].

Masui. The Japanese journal of anesthesiology, 2013

Research

Duloxetine for treating painful neuropathy or chronic pain.

The Cochrane database of systematic reviews, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.